Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

3 articles from the last 90 days matching "bmd"

Clinical trialCLINICALTRIALSMay 12

Trial Now Recruiting: Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases (NCT06285539)

Researchers are testing a new drug approach for three rare immune diseases: Behçet's disease, inflammatory myopathy (muscle inflammation), and IgG4-related disease. Currently, patients with these conditions take strong steroids and other immunosuppressive medications for long periods, which can cause serious side effects like infections. This trial is looking for a safer alternative treatment option.

WHY IT MATTERSIf you have Behçet's disease, idiopathic inflammatory myopathy, or IgG4-related disease and are struggling with side effects from long-term steroid use, this Phase 2 trial is actively recruiting 60 patients and may offer access to a potentially safer treatment option.
→ You can act on thisBehçet's diseaseIdiopathic inflammatory myopathyIgG4-related disease
Clinical trialCLINICALTRIALSMay 4

Trial Now Recruiting: National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases (NCT06491615)

The eyeGENE program is a national registry that collects genetic information, eye imaging, and DNA samples from people with inherited eye diseases. Researchers use this information to understand what causes these diseases and develop better treatments. The program is now expanding and looking for 1,000 more participants with various rare inherited eye conditions.

WHY IT MATTERSIf you have one of the listed inherited eye diseases (like Best disease, aniridia, or albinism), joining this registry could help researchers discover new treatments while contributing your genetic data to advance understanding of your specific condition.
→ You can act on thisBest diseaseAniridiaAlbinism
Clinical trialCLINICALTRIALSApr 30

New Clinical Trial: A Multi-Dimensional Model of cAre and transItion for Patients With cOmplex RAre Diseases (NCT07558213)

Researchers are studying a new care model designed to help patients with complex rare diseases get better coordinated treatment and support. The trial involves 136 patients with conditions like mitochondrial diseases and muscular dystrophies. The goal is to bridge the gap between scientific discoveries and actual patient care by creating a more organized system for managing these complicated conditions.

WHY IT MATTERSThis trial is testing a coordinated care approach specifically for patients with multiple rare diseases or complex symptoms, which could improve how you receive care across different specialists and reduce the fragmentation many rare disease patients experience.
ℹ Good to knowMitochondrial DiseasesMuscular DystrophiesDysmorphic Disorder

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases